Open AccessA Pilot Trial of Indinavir, Ritonavir, Didanosine, and Lamivudine in a Once-Daily Four-Drug Regimen for HIV Infection
Author(s) -
L Molé,
Don Schmidgall,
Mark Holodniy
Publication year - 2001
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/00126334-200107010-00007
Subject(s) - indinavir , didanosine , ritonavir , lamivudine , medicine , viral load , nelfinavir , gastroenterology , stavudine , zalcitabine , regimen , pharmacology , immunology , human immunodeficiency virus (hiv) , virus , hepatitis b virus , antiretroviral therapy
To evaluate the tolerance, pharmacokinetics, and virologic and immunologic outcomes of once-daily indinavir, ritonavir, didanosine, and lamivudine in HIV-seropositive individuals.